|
1
|
Poewe W, Seppi K, Tanner CM, Halliday GM,
Brundin P, Volkmann J, Schrag AE and Lang AE: Parkinson disease.
Nat Rev Dis Primers. 3(17013)2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Nicholls DG: Mitochondrial membrane
potential and aging. Aging Cell. 3:35–40. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zorov DB, Juhaszova M and Sollott SJ:
Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS
release. Physiol Rev. 94:909–950. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ganguly G, Chakrabarti S, Chatterjee U and
Saso L: Proteinopathy, oxidative stress and mitochondrial
dysfunction: Cross talk in Alzheimer's disease and Parkinson's
disease. Drug Des Devel Ther. 11:797–810. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dias V, Junn E and Mouradian MM: The role
of oxidative stress in Parkinson's disease. J Parkinsons Dis.
3:461–491. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Subramaniam SR and Chesselet MF:
Mitochondrial dysfunction and oxidative stress in Parkinson's
disease. Prog Neurobiol. 106-107:17–32. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Heikkila RE, Nicklas WJ, Vyas I and
Duvoisin RC: Dopaminergic toxicity of rotenone and the
1-methyl-4-phenylpyridinium ion after their stereotaxic
administration to rats: Implication for the mechanism of
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Neurosci
Lett. 62:389–394. 1985.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Johnson ME and Bobrovskaya L: An update on
the rotenone models of Parkinson's disease: Their ability to
reproduce the features of clinical disease and model
gene-environment interactions. Neurotoxicology. 46:101–116.
2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Maturana MG, Pinheiro AS, de Souza TL and
Follmer C: Unveiling the role of the pesticides paraquat and
rotenone on α-synuclein fibrillation in vitro. Neurotoxicology.
46:35–43. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ye J, Jiang Z, Chen X, Liu M, Li J and Liu
N: Electron transport chain inhibitors induce microglia activation
through enhancing mitochondrial reactive oxygen species production.
Exp Cell Res. 340:315–326. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yuan YH, Sun JD, Wu MM, Hu JF, Peng SY and
Chen NH: Rotenone could activate microglia through NFkB associated
pathway. Neurochem Res. 38:1553–1560. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Xu ZQ, Zhou Y, Shao BZ, Zhang JJ and Liu
C: A systematic review of neuroprotective efficacy and safety of
DL-3-N-butylphthalide in ischemic stroke. Am J Chin Med.
47:507–525. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chinese Society of Cerebral Blood Flow and
Metabolism. The Chinese guidelines for the evaluation and
management of cerebral collateral circulation in ischemic stroke
(2017). Zhonghua Nei Ke Za Zhi. 56:460–471. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
14
|
Wang S, Ma F, Huang L, Zhang Y and Peng Y,
Xing C, Feng Y, Wang X and Peng Y: Dl-3-n-butylphthalide (NBP): A
promising therapeutic agent for ischemic stroke. CNS Neurol Disord
Drug Targets. 17:338–347. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Huang L, Wang S, Ma F, Zhang Y and Peng Y,
Xing C, Feng Y, Wang X and Peng Y: From stroke to neurodegenerative
diseases: The multi-target neuroprotective effects of
3-n-butylphthalide and its derivatives. Pharmacol Res. 135:201–211.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Luo R, Wangqin R, Zhu L and Bi W:
Neuroprotective mechanisms of 3-n-butylphthalide in
neurodegenerative diseases. Biomed Rep. 11:235–240. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhao CY, Lei H, Zhang Y, Li L, Xu SF, Cai
J, Li PP, Wang L, Wang XL and Peng Y: L-3-n-Butylphthalide
attenuates neuroinflammatory responses by downregulating JNK
activation and upregulating Heme oxygenase-1 in
lipopolysaccharide-treated mice. J Asian Nat Prod Res. 18:289–302.
2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yang XD, Cen ZD, Cheng HP, Shi K, Bai J,
Xie F, Wu HW, Li BB and Luo W: L-3-n-butylphthalide protects HSPB8
K141N mutation-induced oxidative stress by modulating the
mitochondrial apoptotic and Nrf2 pathways. Front Neurosci.
11(402)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu Z, Wang H, Shi X, Li L, Zhou M, Ding
H, Yang Y, Li X and Ding K: DL-3-n-butylphthalide (NBP) provides
neuroprotection in the mice models after traumatic brain injury via
Nrf2-ARE signaling pathway. Neurochem Res. 42:1375–1386.
2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li Q, Cheng Y, Bi M, Lin H, Chen Y, Zou Y,
Liu Y, Kang H and Guo Y: Effects of N-butylphthalide on the
activation of Keap1/Nrf-2 signal pathway in rats after carbon
monoxide poisoning. Environ Toxicol Pharmacol. 40:22–29.
2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhu BL, Xie CL, Hu NN, Zhu XB and Liu CF:
Inhibiting of GRASP65 phosphorylation by DL-3-N-butylphthalide
protects against cerebral ischemia-reperfusion injury via ERK
signaling. Behav Neurol. 2018(5701719)2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang S, Huang L, Zhang Y and Peng Y, Wang
X and Peng Y: Protective effects of L-3-n-butylphthalide against
H2O2-induced injury in neural stem cells by activation of PI3K/Akt
and mash1 pathway. Neuroscience. 393:164–174. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen J, Wang J, Zhang J and Pu C:
3-n-Butylphthalide reduces the oxidative damage of muscles in an
experimental autoimmune myositis animal model. Exp Ther Med.
14:2085–2093. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bose A and Beal MF: Mitochondrial
dysfunction in Parkinson's disease. J Neurochem. 139 (Suppl
1):216–231. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Pivovarov AS, Calahorro F and Walker RJ:
Na(+)/K(+)-pump and neurotransmitter membrane receptors. Invert
Neurosci. 19(1)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Giacomello M, Pyakurel A, Glytsou C and
Scorrano L: The cell biology of mitochondrial membrane dynamics.
Nat Rev Mol Cell Biol. 21:204–224. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zorova LD, Popkov VA, Plotnikov EY,
Silachev DN, Pevzner IB, Jankauskas SS, Babenko VA, Zorov SD,
Balakireva AV, Juhaszova M, et al: Mitochondrial membrane
potential. Anal Biochem. 552:50–59. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sakamuru S, Attene-Ramos MS and Xia M:
Mitochondrial membrane potential assay. Methods Mol Biol.
1473:17–22. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Mitsuishi Y, Motohashi H and Yamamoto M:
The Keap1-Nrf2 system in cancers: Stress response and anabolic
metabolism. Front Oncol. 2(200)2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lu MC, Ji JA, Jiang ZY and You QD: The
Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic
target: An update. Med Res Rev. 36:924–963. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Loboda A, Damulewicz M, Pyza E, Jozkowicz
A and Dulak J: Role of Nrf2/HO-1 system in development, oxidative
stress response and diseases: An evolutionarily conserved
mechanism. Cell Mol Life Sci. 73:3221–3247. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chau LY: Heme oxygenase-1: Emerging target
of cancer therapy. J Biomed Sci. 22(22)2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chen QM and Maltagliati AJ: Nrf2 at the
heart of oxidative stress and cardiac protection. Physiol Genomics.
50:77–97. 2018.PubMed/NCBI View Article : Google Scholar
|
